-+ 0.00%
-+ 0.00%
-+ 0.00%

NEUROSENSE: IN CANADA, PLANS TO SUBMIT DOSSIER IN Q2 2025, WITH REGULATORY DECISION ON COMMERCIALIZATION EXPECTED BY Q1 2026

Reuters·10/28/2024 12:31:12

Please log in to view news